Skip to main content
Erschienen in: Endocrine 3/2019

02.09.2019 | Original Article

Heterogenous nature of gene expression patterns in BRAF-like papillary thyroid carcinomas with BRAFV600E

verfasst von: Yuji Nagayama, Hiroyuki Mishima

Erschienen in: Endocrine | Ausgabe 3/2019

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Papillary thyroid cancers (PTCs) are the most common type of thyroid cancers, in which BRAFV600E is the most prevalent driver mutation. It is known that BRAFV600E-positive PTCs are clinically and molecularly heterogenous in terms of aggressiveness and prognosis. The molecular mechanisms of this heterogeneity were evaluated.

Methods

The publicly available RNA-seq data for 26 classical (c) and 5 follicular variant (fv) PTCs with BRAFV600E mutation and the BRAF-like expression signature in the BRAFV600E-RAS score (BRS) and their respective normal adjacent tissues were downloaded, and analyzed for differentially expressed genes (DEGs). The DEGs were then analyzed with the Gene Ontology annotation and the KEGG pathway dataset.

Results

We found four lines of evidence for heterogeneity of cPTCs. First, the cluster dendrogram and principle component analyses could not completely distinguish the cancer tissues from normal tissues. Second, the DEGs identified in each sample were highly diverse from one another. Third, although the DEGs were enriched in many terms containing the word “extracellular” (“extracellular region”, “extracellular space”, and so on) when analyzed as groups, the degree of this enrichment was variable when analyzed individually. Fourth, there are only a few intersections in the over-/underexpressed genes annotated with the terms containing the word “extracellular” among the samples examined. Essentially same results were obtained with BRAF-like, fvPTCs with BRAFV600E. Nevertheless, some frequently over-/underexpressed genes were detected, of which LIPH (lipase H) expression was found to be prognostic and its high expression was favorable for PTCs.

Conclusion

Groups of BRAF-like, BRAFV600E-positive cPTCs and fvPTCs that are homogenous in regard to histopathology, driver mutation and BRS were found to be highly heterogenous in terms of gene expression patterns. Yet, among the genes that were annotated with the terms containing the word “extracellular” and frequently over-/underexpressed, LIPH is a favorable prognostic marker for PTCs.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
3.
Zurück zum Zitat B.R. Haugen, E.K. Alexander, K.C. Bible, G.M. Doherty, S.J. Mandel, Y.E. Nikiforov, F. Pacini, G.W. Randolph, A.M. Sawka, M. Schlumberger, K.G. Schuff, S.I. Sherman, J.A. Sosa, D.L. Steward, R.M. Tuttle, L. Wartofsky, 2015 American Thyroid Association Management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid 26(1), 1–133 (2016). https://doi.org/10.1089/thy.2015.0020 CrossRefPubMedPubMedCentral B.R. Haugen, E.K. Alexander, K.C. Bible, G.M. Doherty, S.J. Mandel, Y.E. Nikiforov, F. Pacini, G.W. Randolph, A.M. Sawka, M. Schlumberger, K.G. Schuff, S.I. Sherman, J.A. Sosa, D.L. Steward, R.M. Tuttle, L. Wartofsky, 2015 American Thyroid Association Management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid 26(1), 1–133 (2016). https://​doi.​org/​10.​1089/​thy.​2015.​0020 CrossRefPubMedPubMedCentral
14.
Zurück zum Zitat Y. Xu, J. Chen, Z. Yang, L. Xu, Identification of RNA expression profiles in thyroid cancer to construct a competing endogenous RNA (ceRNA) network of mRNAs, long Noncoding RNAs (lncRNAs), and microRNAs (miRNAs). Med. Sci. Monit.: Int. Med. J. Exp. Clin. Res. 25, 1140–1154 (2019). https://doi.org/10.12659/msm.912450 CrossRef Y. Xu, J. Chen, Z. Yang, L. Xu, Identification of RNA expression profiles in thyroid cancer to construct a competing endogenous RNA (ceRNA) network of mRNAs, long Noncoding RNAs (lncRNAs), and microRNAs (miRNAs). Med. Sci. Monit.: Int. Med. J. Exp. Clin. Res. 25, 1140–1154 (2019). https://​doi.​org/​10.​12659/​msm.​912450 CrossRef
15.
Zurück zum Zitat I. Reyes, N. Reyes, R. Suriano, C. Iacob, N. Suslina, A. Policastro, A. Moscatello, S. Schantz, R.K. Tiwari, J. Geliebter, Gene expression profiling identifies potential molecular markers of papillary thyroid carcinoma. Cancer Biomark. 24(1), 71–83 (2019). https://doi.org/10.3233/cbm-181758 CrossRefPubMed I. Reyes, N. Reyes, R. Suriano, C. Iacob, N. Suslina, A. Policastro, A. Moscatello, S. Schantz, R.K. Tiwari, J. Geliebter, Gene expression profiling identifies potential molecular markers of papillary thyroid carcinoma. Cancer Biomark. 24(1), 71–83 (2019). https://​doi.​org/​10.​3233/​cbm-181758 CrossRefPubMed
17.
Zurück zum Zitat I. Landa, T. Ibrahimpasic, L. Boucai, R. Sinha, J.A. Knauf, R.H. Shah, S. Dogan, J.C. Ricarte-Filho, G.P. Krishnamoorthy, B. Xu, N. Schultz, M.F. Berger, C. Sander, B.S. Taylor, R. Ghossein, I. Ganly, J.A. Fagin, Genomic and transcriptomic hallmarks of poorly differentiated and anaplastic thyroid cancers. J. Clin. Investig. 126(3), 1052–1066 (2016). https://doi.org/10.1172/jci85271 CrossRefPubMedPubMedCentral I. Landa, T. Ibrahimpasic, L. Boucai, R. Sinha, J.A. Knauf, R.H. Shah, S. Dogan, J.C. Ricarte-Filho, G.P. Krishnamoorthy, B. Xu, N. Schultz, M.F. Berger, C. Sander, B.S. Taylor, R. Ghossein, I. Ganly, J.A. Fagin, Genomic and transcriptomic hallmarks of poorly differentiated and anaplastic thyroid cancers. J. Clin. Investig. 126(3), 1052–1066 (2016). https://​doi.​org/​10.​1172/​jci85271 CrossRefPubMedPubMedCentral
23.
Zurück zum Zitat D. Luo, H. Chen, P. Lu, X. Li, M. Long, X. Peng, M. Huang, K. Huang, S. Lin, L. Tan, Y. Zhu, Z. Chen, N. Ouyang, H. Li, CHI3L1 overexpression is associated with metastasis and is an indicator of poor prognosis in papillary thyroid carcinoma. Cancer Biomark. 18(3), 273–284 (2017). https://doi.org/10.3233/cbm-160255 CrossRefPubMed D. Luo, H. Chen, P. Lu, X. Li, M. Long, X. Peng, M. Huang, K. Huang, S. Lin, L. Tan, Y. Zhu, Z. Chen, N. Ouyang, H. Li, CHI3L1 overexpression is associated with metastasis and is an indicator of poor prognosis in papillary thyroid carcinoma. Cancer Biomark. 18(3), 273–284 (2017). https://​doi.​org/​10.​3233/​cbm-160255 CrossRefPubMed
28.
Zurück zum Zitat M. Sponziello, F. Rosignolo, M. Celano, V. Maggisano, V. Pecce, R.F. De Rose, G.E. Lombardo, C. Durante, S. Filetti, G. Damante, D. Russo, S. Bulotta, Fibronectin-1 expression is increased in aggressive thyroid cancer and favors the migration and invasion of cancer cells. Mol. Cell. Endocrinol. 431, 123–132 (2016). https://doi.org/10.1016/j.mce.2016.05.007 CrossRefPubMed M. Sponziello, F. Rosignolo, M. Celano, V. Maggisano, V. Pecce, R.F. De Rose, G.E. Lombardo, C. Durante, S. Filetti, G. Damante, D. Russo, S. Bulotta, Fibronectin-1 expression is increased in aggressive thyroid cancer and favors the migration and invasion of cancer cells. Mol. Cell. Endocrinol. 431, 123–132 (2016). https://​doi.​org/​10.​1016/​j.​mce.​2016.​05.​007 CrossRefPubMed
Metadaten
Titel
Heterogenous nature of gene expression patterns in BRAF-like papillary thyroid carcinomas with BRAFV600E
verfasst von
Yuji Nagayama
Hiroyuki Mishima
Publikationsdatum
02.09.2019
Verlag
Springer US
Erschienen in
Endocrine / Ausgabe 3/2019
Print ISSN: 1355-008X
Elektronische ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-019-02063-z

Weitere Artikel der Ausgabe 3/2019

Endocrine 3/2019 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.